Insiders · Profile

Roberts Zachary

EVP of R&D at Allogene Therapeutics. Filing since 21 Jan 2025. CIK 0001851044

Company
Date
Role
Action
Shares
Amount
Of holding
2 Feb 2026
EVP of R&D
Sold at will
35,700
$63.19K
5.8%
21 Jan 2026
EVP of R&D
Sold at will
26,269
$40.98K
4.1%
3 Feb 2025
EVP of R&D
Sold at will
18,832
$32.01K
2.8%
21 Jan 2025
EVP of R&D
Sold at will
27,199
$48.41K
5.3%
4 decisions on file.